Skip to main content

InvestorNewsBreaks – Grapefruit USA Inc. (GPFT) CEO Releases Comment Regarding NFL’s $1M Award to Study Cannabis, CBD to Manage Pain

Grapefruit USA (OTCQB: GPFT), an innovative California-based cannabiotech company, has made comments on the recent news that the National Football League (“NFL”) awarded $1 million to two teams of medical researchers: one from the University of San Diego and the second team from the University of Regina in Canada. The funds are earmarked to study the effects of cannabinoids, including cannabis, on pain management and neuroprotection from concussion in NFL players. Specifically, the San Diego-based group will investigate the effects of cannabinoids on pain caused by and recovery from sports-related injuries in NFL players. The University of Regina medical team will investigate the use of naturally produced cannabinoids to manage pain and concussions, which occur routinely in contact sports such as organized football. “The NFL’s $1 million research grant is a very forward-looking move by the league to foster the use of cannabinoids to manage pain and concussions,” said Grapefruit cofounder and CEO Bradley J. Yourist in the press release. “The NFL is wisely following Grapefruit’s efforts to investigate the efficacy of cannabinoids in the fight against sports-originated pain and concussion. While we are gratified to have these NFL initiatives validate Grapefruit’s efforts to research the use of cannabinoids to solve the problems of sports-related pain and concussion, our customers’ experiences inform us that Grapefruit’s patented Hourglass THC/CBD and CBD only products provide our customers with the holistic benefits of cannabinoids without facing the dangers of smoking or eating cannabinoid-based products. It is gratifying to see the NFL follow Grapefruit’s lead.”

To view the full press release, visit https://ibn.fm/41gyP

About Grapefruit USA Inc.

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. To find out more about the company, please visit https://GrapefruitBlvd.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.